Cabaletta Bio (CABA)
(Delayed Data from NSDQ)
$6.71 USD
-0.17 (-2.47%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $6.71 0.00 (0.00%) 5:14 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.51 |
Last EPS Surprise | -6.25% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.07 |
Next Year | -2.39 |
EPS (TTM) | -1.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.51 | -2.07 | -2.39 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.47 | -0.51 | -2.03 | -2.31 |
High Estimate | -0.44 | -0.44 | -1.83 | -2.15 |
Low Estimate | -0.73 | -0.60 | -2.32 | -2.88 |
Year ago EPS | -0.37 | -0.37 | -1.65 | -2.07 |
Year over Year Growth Est. | -48.65% | -37.84% | -25.45% | -15.47% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.51 | -2.07 | -2.39 |
7 Days Ago | -0.55 | -0.51 | -2.07 | -2.39 |
30 Days Ago | -0.55 | -0.51 | -2.07 | -2.39 |
60 Days Ago | -0.55 | -0.51 | -2.07 | -2.39 |
90 Days Ago | -0.47 | -0.45 | -1.82 | -2.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.51 | -2.07 | -2.39 |
Zacks Consensus Estimate | -0.55 | -0.51 | -2.07 | -2.39 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.51 | -0.46 | -0.37 | -0.37 | NA |
Estimate | -0.48 | -0.39 | -0.39 | -0.47 | NA |
Difference | -0.03 | -0.07 | 0.02 | 0.10 | 0.01 |
Surprise | -6.25% | -17.95% | 5.13% | 21.28% | 0.55% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more